FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309368082> ?p ?o ?g. }

• W4309368082 abstract "ABSTRACT Objectives The objective of the study was to report the efficacy and safety of canakinumab treatment in Japanese patients with systemic juvenile idiopathic arthritis (sJIA) over a 48-week study period. Methods Patients were administered canakinumab 4 mg/kg (maximum dose 300 mg) every 4 weeks, with no dose adjustments. The key outcome measures included adapted American College of Rheumatology paediatric (aACR pedi) 30/50/70/90/100 response, proportion of patients with inactive disease, and corticosteroid (CS) tapering. Results In total, 16/19 (84.2%) patients received canakinumab for ≥96 weeks reaching end-of-study (EOS) visit without premature discontinuation. Regardless of the level of joint involvement at baseline, high aACR pedi responses were observed throughout the study; at the EOS, aACR pedi 90/100 response rates were 84.2%/63.2%, respectively. The proportion of patients who successfully tapered CSs at EOS was 66.7% (12/18), of which 10 patients were steroid-free. The most common adverse events were infections (238.3 events/100 patient-years). Serious adverse events were observed in 52.6%. The event (n=1) adjudicated as possible macrophage activation syndrome was preceded by sJIA flare. No deaths were reported. Conclusions Canakinumab treatment resulted in a sustained treatment response in sJIA patients over 48 weeks and was associated with CS tapering in majority of patients. No new safety findings were reported." @default.
• W4309368082 created "2022-11-26" @default.
• W4309368082 creator A5006703809 @default.
• W4309368082 creator A5015137967 @default.
• W4309368082 creator A5022766840 @default.
• W4309368082 creator A5024315206 @default.
• W4309368082 creator A5030324437 @default.
• W4309368082 creator A5040164504 @default.
• W4309368082 creator A5055492436 @default.
• W4309368082 creator A5075162981 @default.
• W4309368082 creator A5075784335 @default.
• W4309368082 creator A5076910379 @default.
• W4309368082 creator A5089406218 @default.
• W4309368082 date "2022-11-18" @default.
• W4309368082 modified "2023-09-23" @default.
• W4309368082 title "Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study" @default.
• W4309368082 cites W1967173230 @default.
• W4309368082 cites W1980034654 @default.
• W4309368082 cites W1998366883 @default.
• W4309368082 cites W2004149792 @default.
• W4309368082 cites W2042084308 @default.
• W4309368082 cites W2054276574 @default.
• W4309368082 cites W2070086022 @default.
• W4309368082 cites W2073700972 @default.
• W4309368082 cites W2075729274 @default.
• W4309368082 cites W2087769239 @default.
• W4309368082 cites W2114155762 @default.
• W4309368082 cites W2120852203 @default.
• W4309368082 cites W2134389576 @default.
• W4309368082 cites W2135974703 @default.
• W4309368082 cites W2141351444 @default.
• W4309368082 cites W2151729372 @default.
• W4309368082 cites W2235714941 @default.
• W4309368082 cites W2275001939 @default.
• W4309368082 cites W2565022774 @default.
• W4309368082 cites W2769476094 @default.
• W4309368082 cites W2893892798 @default.
• W4309368082 cites W3036370495 @default.
• W4309368082 doi "https://doi.org/10.1093/mr/roac128" @default.
• W4309368082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36399020" @default.
• W4309368082 hasPublicationYear "2022" @default.
• W4309368082 type Work @default.
• W4309368082 citedByCount "0" @default.
• W4309368082 crossrefType "journal-article" @default.
• W4309368082 hasAuthorship W4309368082A5006703809 @default.
• W4309368082 hasAuthorship W4309368082A5015137967 @default.
• W4309368082 hasAuthorship W4309368082A5022766840 @default.
• W4309368082 hasAuthorship W4309368082A5024315206 @default.
• W4309368082 hasAuthorship W4309368082A5030324437 @default.
• W4309368082 hasAuthorship W4309368082A5040164504 @default.
• W4309368082 hasAuthorship W4309368082A5055492436 @default.
• W4309368082 hasAuthorship W4309368082A5075162981 @default.
• W4309368082 hasAuthorship W4309368082A5075784335 @default.
• W4309368082 hasAuthorship W4309368082A5076910379 @default.
• W4309368082 hasAuthorship W4309368082A5089406218 @default.
• W4309368082 hasBestOaLocation W43093680821 @default.
• W4309368082 hasConcept C126322002 @default.
• W4309368082 hasConcept C187212893 @default.
• W4309368082 hasConcept C197934379 @default.
• W4309368082 hasConcept C198451711 @default.
• W4309368082 hasConcept C2777077863 @default.
• W4309368082 hasConcept C2777226972 @default.
• W4309368082 hasConcept C2777575956 @default.
• W4309368082 hasConcept C2778715236 @default.
• W4309368082 hasConcept C2779134260 @default.
• W4309368082 hasConcept C2779613421 @default.
• W4309368082 hasConcept C2779725882 @default.
• W4309368082 hasConcept C2781228260 @default.
• W4309368082 hasConcept C3018359032 @default.
• W4309368082 hasConcept C71924100 @default.
• W4309368082 hasConceptScore W4309368082C126322002 @default.
• W4309368082 hasConceptScore W4309368082C187212893 @default.
• W4309368082 hasConceptScore W4309368082C197934379 @default.
• W4309368082 hasConceptScore W4309368082C198451711 @default.
• W4309368082 hasConceptScore W4309368082C2777077863 @default.
• W4309368082 hasConceptScore W4309368082C2777226972 @default.
• W4309368082 hasConceptScore W4309368082C2777575956 @default.
• W4309368082 hasConceptScore W4309368082C2778715236 @default.
• W4309368082 hasConceptScore W4309368082C2779134260 @default.
• W4309368082 hasConceptScore W4309368082C2779613421 @default.
• W4309368082 hasConceptScore W4309368082C2779725882 @default.
• W4309368082 hasConceptScore W4309368082C2781228260 @default.
• W4309368082 hasConceptScore W4309368082C3018359032 @default.
• W4309368082 hasConceptScore W4309368082C71924100 @default.
• W4309368082 hasLocation W43093680821 @default.
• W4309368082 hasLocation W43093680822 @default.
• W4309368082 hasOpenAccess W4309368082 @default.
• W4309368082 hasPrimaryLocation W43093680821 @default.
• W4309368082 hasRelatedWork W2055478507 @default.
• W4309368082 hasRelatedWork W2066059652 @default.
• W4309368082 hasRelatedWork W2128871880 @default.
• W4309368082 hasRelatedWork W2142659423 @default.
• W4309368082 hasRelatedWork W2155894437 @default.
• W4309368082 hasRelatedWork W2565393302 @default.
• W4309368082 hasRelatedWork W3024688657 @default.
• W4309368082 hasRelatedWork W3036370495 @default.
• W4309368082 hasRelatedWork W3114048118 @default.
• W4309368082 hasRelatedWork W4309368082 @default.
• W4309368082 isParatext "false" @default.
• W4309368082 isRetracted "false" @default.

• next